Friday, April 3, 2026

Why Wasn’t Tesla a Part of the ‘NVIDIA party’?

NVIDIA announced earnings that exceeded market expectations, sparking an artificial intelligence (AI) rally on Wall Street.

The New Model Y Is Here—Sharper Looks, Smoother Ride, Same Tesla DNA

Tesla Korea launches the new Model Y with enhanced design and features, offering three variants and impressive range and efficiency.

Hyundai’s Massive Driving Experience Center Kicks Off 2025 Season

Hyundai Motor Group launches the 2025 season of the HMG Driving Experience Center, featuring advanced driving courses and programs.

Tag: FGFR2

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Top News

- Our Sponsors Ad -

Follow us